Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Precigen, Inc. (NASDAQ: PGEN), a forward-thinking player in the biotechnology sector, is making waves with its innovative gene and cell therapy solutions. With a market capitalization of $1.13 billion, Precigen..
For investors with an appetite for high-growth opportunities in the biotechnology sector, PureTech Health plc (NASDAQ: PRTC) presents a compelling case. Based in Boston, Massachusetts, and incorporated in 2015, this..
Arvinas, Inc. (NASDAQ: ARVN) has captured the attention of investors with its innovative approach to biotechnology, focusing on developing therapies to degrade disease-causing proteins. As a clinical-stage company, Arvinas is..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology firm, is currently attracting significant investor attention with its robust pipeline aimed at addressing unmet medical needs, particularly in the treatment of..
Orthofix Medical Inc. (NASDAQ: OFIX), a significant player in the medical devices sector, is attracting attention with its promising upside potential, despite recent financial challenges. The company, headquartered in Lewisville,..
Humacyte, Inc. (NASDAQ: HUMA), a pioneering company in the healthcare sector, stands out in the biotechnology industry with its innovative approach to developing implantable bioengineered human tissues. With a market..
Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector, operates within the specialized medical devices industry. With a current market capitalization of $411.91 million, the company offers innovative..
Abivax SA (ABVX), a prominent player in the biotechnology sector, is capturing investor interest with a compelling growth narrative and substantial upside potential. With its headquarters in Paris, France, the..
Investors eyeing Fortrea Holdings Inc. (NASDAQ: FTRE) are met with a complex picture defined by an evolving market position and strategic initiatives within the healthcare sector. This biotechnology company, based..
Investors keen on the biotechnology sector should keep a close watch on MBX Biosciences, Inc. (MBX), a promising player with a focus on precision peptide therapies for treating endocrine and..
Septerna, Inc. (SEPN), a burgeoning player in the biotechnology sector, is garnering attention from both investors and analysts alike. With a market cap of $1.03 billion, the company is making..
Castle Biosciences, Inc. (NASDAQ: CSTL), a key player in the healthcare sector, specializes in molecular diagnostics, offering innovative test solutions for dermatologic cancers and mental health conditions. With a market..
For investors with a keen eye on the biotechnology sector, AnaptysBio, Inc. (NASDAQ: ANAB) presents an intriguing opportunity. This San Diego-based clinical-stage company is making strides in immunology therapeutics, developing..
Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA), a pioneer in the field of synthetic biology, operates at the cutting edge of biotechnology. Headquartered in Boston, Massachusetts, the company is renowned for..
Sana Biotechnology, Inc. (NASDAQ: SANA) has captured the interest of investors with its innovative approach to cell engineering and a standout potential upside of 82.99%. Operating within the healthcare sector,..
Zenas BioPharma, Inc. (ZBIO), a clinical-stage biopharmaceutical company, has been capturing significant attention in the biotechnology sector with its focus on transformative immunology-based therapies. Headquartered in Waltham, Massachusetts, Zenas BioPharma..
Tourmaline Bio, Inc. (TRML) is making waves in the healthcare sector, particularly within the biotechnology industry. Based in New York, this clinical-stage company is focused on developing innovative treatments for..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector with a focus on medical devices, presents a compelling investment case with a potential upside of 30.51% according..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a biopharmaceutical company specializing in oncology therapies, has caught the attention of investors with a potential upside of 131.48%. This impressive figure is driven by..
ATAI Life Sciences N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector, particularly in the field of mental health treatments. With a market capitalization of $1.27 billion and a..
